LIVE DONOR RENAL ALLOGRAFT IN END-STAGE RENAL FAILURE PATIENTS FROM IMMUNOGLOBULIN A NEPHROPATHY1,2

Abstract

Recurrence increased to 44% with longer follow-up, but this did not limit the graft outcome. Recurrence was not affected by the kind of live donor. We conclude that live related or unrelated kidneys should be offered to IgAN patients.